Generic drugs are supposed to give consumers more choices and a counterweight to more costly branded medications. During his tenure as FDA commissioner, Scott Gottlieb often spoke about generics as a market force that could help tame climbing drug prices. But... Read more »
The world’s biggest annual cancer conference is just around the corner. Data presented at the American Society of Clinical Oncology meeting each year can change medical practice and make or break companies whose drugs are under the microscope. That’s what makes... Read more »
Austin—MassChallenge has picked the 74 early-stage companies that will eventually compete for a portion of $500,000 in cash as a part of its Austin accelerator program. They’re startups that are developing products in a wide range of sectors, including life... Read more »
CrowdStrike, the cybersecurity company that identified the two Russian government-linked hacker groups that invaded the Democratic National Committee (DNC)’s network during the 2016 presidential campaign, filed publicly for an initial public offering on Tuesday.
Sunnyvale, CA-based CrowdStrike sells cloud-based security... Read more »
Algorithmia was founded on the idea that lots of people who write algorithms, from academics to private sector employees, have good products but no way to commercialize them. It launched in 2014 as a marketplace for people who want to buy... Read more »
Let’s catch up with the latest innovation news in Texas.
—Innowatts, an AI-focused energy tech company in Houston, has closed an $18.2 million Series B funding round, according to a press release. The investment was led by Energy Impact... Read more »
It’s been a little over a year since Carbon Black debuted on the Nasdaq stock exchange, raising $152 million selling its shares to the public for the first time.
The Waltham, MA-based cybersecurity company’s stock price (NASDAQ: CBLK) has bounced... Read more »
With Uber’s long-awaited IPO, Facebook’s mounting controversies, and ongoing debates over drug pricing and safety issues, come a great responsibility. A big story in the innovation community now is about the ethics and regulation of tech and life sciences. What are... Read more »
The market for drugs for rare or “orphan” diseases continues to grow. An April report from Evaluate Pharma predicted sales of orphan drugs to rise 12 percent a year between now and 2024, when they will account for an estimated 20... Read more »
[Updated 5/10/19, 5 pm ET. See below.] Ride-hailing giant Uber secured $8.1 billion in new capital late Thursday as it priced an initial public offering that set its market capitalization at $82.4 billion, according to calculations by The... Read more »
It will be hard to top last year’s flurry of biotech companies joining the public markets, but this week is shaping up to be the busiest for life science IPOs in recent memory. Five biotechs priced their IPOs and at least... Read more »
The American Academy of Neurology meeting in Philadelphia is rolling on through the end of this week. There has been plenty of news to digest already. New clinical data could herald cutting-edge treatments for migraine, the rare disease spinal muscular atrophy,... Read more »
San Antonio—MedCognition, a startup that uses an augmented reality system to train emergency medical technicians and other first responders on how to treat injuries, has earned a $750,000 grant from the US Army to collaborate with another organization on developing... Read more »